South Korea Thursday fined Swiss pharma Novartis $48.3 million for paying doctors kickbacks to prescribe the company's drugs.
Entries in China (773)
Pharmaceuticals companies continue to fall foul of the FCPA and other anti-bribery laws, with a number of 2016 cases suggesting a vulnerability around marketing practices especially in the Asia-Pacific region. Why does a sector that is way ahead of the compliance game in so many ways keep getting caught out by anti-bribery laws?
China's Ministry of Public Security said 951 fugitives suspected of white-collar crimes were captured from 72 countries last year through Operation Fox Hunt.
At a time when U.S. leadership in the world is no longer a surety, we should be comforted to find another western hemisphere country proudly taking the lead.
A survey in Asia by Transparency International found that just over one in four people had paid a bribe to access public services during the prior year.
China recently released a revised draft of amendments to its law governing commercial bribery that would scale back some of the more far-reaching changes in a draft released last year while returning to a broader scope of commercial bribery.
Citigroup Inc. said Friday it is being investigated for hiring practices that might violate the FCPA.
Donald Tsang, Hong Kong's Chief Executive between 2005 and 2012, was sentenced Wednesday to 20 months in prison.
What does the failure of the Kraft Heinz attempted hostile takeover of Unilever portend for the greater world of global anti-corruption enforcement specifically and compliance programs more generally?
A federal jury Thursday convicted a Chinese scientist of conspiring to steal rice seeds from a Kansas biopharmaceutical research facility.
China announced a new policy this month that aims to reduce corruption and control the price of pharmaceuticals by effectively requiring there to be at most one distributor between the pharmaceutical manufacturer and the end hospital.
Las Vegas Sands Corp. agreed Thursday to pay a criminal fine of nearly $7 million for Foreign Corrupt Practices Act offenses in China and Macau.